← Leaderboards
Rebecca Brown
National Institute Of Diabetes And Digestive And Kidney Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Insulin Resistance”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- C Ronald Kahn · Joslin Diabetes Center$58,520,009
- Leonardo Trasande · New York University School Of Medicine$54,198,824
- Walter N Kernan · Yale University$53,085,019
- Jose A Luchsinger · Columbia University Health Sciences$36,610,547
- Domenico Accili · Columbia University Health Sciences$31,951,136
Research focus
Insulin ResistanceLipodystrophyAdipose TissueDiabetes MellitusTriglyceridesRare DiseasesEndocrineMetabolicHormonesInsulin ReceptorMutationInsulinLiverEnergy MetabolismAdipocytesLeptinEatingLeptin DeficiencyFatty Acid Glycerol EstersFastingNon-Alcoholic Fatty Liver DiseaseLipolysisCardiovascular DiseasesGenes
Grant awards (46)
Molecular and Clinical Studies of Insulin Resistance$833,192
ZIA · FY2025 · DK · contact PI
Clinical utility of leptin therapy in syndromic forms of insulin resistance.$416,596
ZIA · FY2025 · DK · contact PI
Growth hormone inhibition in severe insulin resistance$333,277
ZIA · FY2025 · DK · contact PI
Postprandial Lipid Metabolism$83,319
ZIA · FY2025 · DK · contact PI
Molecular and Clinical Studies of Insulin Resistance$589,467
ZIA · FY2024 · DK · contact PI
Clinical utility of leptin therapy in syndromic forms of insulin resistance.$589,467
ZIA · FY2024 · DK · contact PI
Growth hormone inhibition in severe insulin resistance$294,733
ZIA · FY2024 · DK · contact PI
Molecular and Clinical Studies of Insulin Resistance$620,124
ZIA · FY2023 · DK · contact PI
Clinical utility of leptin therapy in syndromic forms of insulin resistance.$513,817
ZIA · FY2023 · DK · contact PI
Growth hormone inhibition in severe insulin resistance$265,767
ZIA · FY2023 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$177,178
ZIA · FY2023 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$177,178
ZIA · FY2023 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$17,718
ZIA · FY2023 · DK · contact PI
Clinical utility of leptin therapy in syndromic forms of insulin resistance.$505,529
ZIA · FY2022 · DK · contact PI
Molecular and Clinical Studies of Insulin Resistance$505,529
ZIA · FY2022 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$144,437
ZIA · FY2022 · DK · contact PI
Growth hormone inhibition in severe insulin resistance$144,437
ZIA · FY2022 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$72,218
ZIA · FY2022 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$72,218
ZIA · FY2022 · DK · contact PI
Clinical utility of leptin therapy in syndromic forms of insulin resistance.$370,211
ZIA · FY2021 · DK · contact PI
Molecular and Clinical Studies of Insulin Resistance$370,211
ZIA · FY2021 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$308,509
ZIA · FY2021 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$123,404
ZIA · FY2021 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$61,702
ZIA · FY2021 · DK · contact PI
Molecular and Clinical Studies of Insulin Resistance$487,152
ZIA · FY2020 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$324,768
ZIA · FY2020 · DK · contact PI
Clinical utility of leptin therapy in syndromic forms of insulin resistance.$324,768
ZIA · FY2020 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$324,768
ZIA · FY2020 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$162,384
ZIA · FY2020 · DK · contact PI
Clinical utility of leptin therapy in syndromic forms of insulin resistance.$250,260
ZIA · FY2019 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$166,840
ZIA · FY2019 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$166,840
ZIA · FY2019 · DK · contact PI
Molecular and Clinical Studies of Insulin Resistance$166,840
ZIA · FY2019 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$83,420
ZIA · FY2019 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$326,284
ZIA · FY2018 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$316,687
ZIA · FY2018 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$316,687
ZIA · FY2018 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$305,663
ZIA · FY2017 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$296,673
ZIA · FY2017 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$296,673
ZIA · FY2017 · DK · contact PI
Apolipoprotein CIII inhibition in partial lipodystrophy$138,779
ZIA · FY2016 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$134,698
ZIA · FY2016 · DK · contact PI
Thyroid hormone in patients with insulin receptor mutations$134,698
ZIA · FY2016 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$276,240
ZIA · FY2015 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$204,368
ZIA · FY2014 · DK · contact PI
Effects of leptin in lipodystrophy independent of food intake$176,556
ZIA · FY2013 · DK · contact PI